 <h1>Lorazepam Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of lorazepam include:</b> sedated state. <b>Other side effects include:</b> dizziness.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to lorazepam: oral solution, oral tablet</i></p><p>Other dosage forms:</p><ul><li>injection solution</li></ul><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve use where alternative treatments are inadequate. Limit the dosage and duration, and monitor signs and symptoms.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, lorazepam may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking lorazepam:</p><p>
<i>More common</i>
</p><ul>
<li>Drowsiness</li>
<li>relaxed and calm</li>
<li>sleepiness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>aggressive, angry</li>
<li>agitation</li>
<li>attack, assault, or force</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>bluish lips or skin</li>
<li>blurred vision</li>
<li>change in consciousness</li>
<li>chills</li>
<li>coma</li>
<li>confusion</li>
<li>confusion about identity, place, and time</li>
<li>convulsions</li>
<li>cough or hoarseness</li>
<li>dark urine</li>
<li>decreased urine output</li>
<li>difficulty with breathing or swallowing</li>
<li>difficulty with speaking</li>
<li>discouragement</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>drooling</li>
<li>dry mouth</li>
<li>excitation</li>
<li>false or unusual sense of well-being</li>
<li>fast or irregular heartbeat</li>
<li>feeling sad or empty</li>
<li>fever with or without chills</li>
<li>general feeling of tiredness or weakness</li>
<li>headache</li>
<li>hives, itching, or rash</li>
<li>hyperventilation</li>
<li>increased thirst</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>irritability</li>
<li>loss of appetite</li>
<li>loss of balance control</li>
<li>loss of consciousness</li>
<li>loss of interest or pleasure</li>
<li>loss of memory</li>
<li>lower back or side pain</li>
<li>muscle pain or cramps</li>
<li>muscle trembling, jerking, or stiffness</li>
<li>nausea or vomiting</li>
<li>not breathing</li>
<li>painful or difficult urination</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>pinpoint red spots on the skin</li>
<li>problems with memory</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>reddening of the skin, especially around ears</li>
<li>restlessness</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>seizures</li>
<li>shaking</li>
<li>shuffling walk</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stiffness of the limbs</li>
<li>sweating</li>
<li>swelling of the eyes or inside of the nose</li>
<li>swelling of the face, ankles, or hands</li>
<li>swollen glands</li>
<li>thoughts or attempts at killing oneself</li>
<li>tightness in the chest</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>twisting movements of body</li>
<li>uncontrolled movements, especially of the face, neck, and back</li>
<li>unexplained bleeding or bruising</li>
<li>unpleasant breath odor</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting of blood</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking lorazepam:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Changes in patterns and rhythms of speech</li>
<li>increased sweating</li>
<li>loss of strength or energy</li>
<li>nightmares</li>
<li>shakiness and unsteady walk</li>
<li>slurred speech</li>
<li>trouble speaking</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
<li>unusual excitement, nervousness, restlessness, or irritability</li>
<li>unusual paleness</li>
<li>unusual weak feeling</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of lorazepam may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Being forgetful</li>
<li>clumsiness</li>
<li>constipation</li>
<li>decreased interest in sexual intercourse</li>
<li>disturbed color perception</li>
<li>dizziness or lightheadedness</li>
<li>double vision</li>
<li>drowsiness</li>
<li>feeling of constant movement of self or surroundings</li>
<li>hair loss or thinning of the hair</li>
<li>halos around lights</li>
<li>inability to have or keep an erection</li>
<li>increased in sexual ability, desire, drive, or performance</li>
<li>increased interest in sexual intercourse</li>
<li>lack or loss of self-control</li>
<li>lethargy</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>muscle aches, twitching, or weakness</li>
<li>night blindness</li>
<li>overbright appearance of lights</li>
<li>rapid weight gain</li>
<li>sensation of spinning</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>shivering</li>
<li>stupor</li>
<li>trembling or shaking of the hands or feet</li>
<li>tunnel vision</li>
<li>weak or feeble pulse</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lorazepam: compounding powder, injectable solution, intravenous solution, oral concentrate, oral tablet</i></p><h3>General</h3><p>Oral: The most commonly reported side effects included sedation, dizziness, weakness, and unsteadiness.</p>
<p></p>
<p>Parenteral: The most commonly reported side effects included somnolence, respiratory failure, hypotension, and injection site reactions (pain and burning).<sup>[Ref]</sup></p><h3>Local</h3><p>Parenteral:</p>
<p><b>Very common</b> (10% or more): Burning (up to 17%), pain (up to 17%)</p>
<p><b>Common</b> (1% to 10%): Painful response, redness</p>
<p><b>Uncommon</b> (0.1% to 1%): Injection site reaction</p>
<p><b>Frequency not reported</b>: Arteriospasm, gangrene, injection site tolerance<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Oral:</p>
<p><b>Very common</b> (10% or more): Sedation (up to 15.9%)</p>
<p><b>Common</b> (1% to 10%): Anterograde amnesia, ataxia, daytime drowsiness, dizziness, drowsiness, unsteadiness</p>
<p><b>Rare</b> (0.01% to 0.1%): Dysarthria, headache, memory impairment, reduced alertness, slurred speech, transient anterograde amnesia</p>
<p><b>Very rare</b> (less than 0.01%): Coma, extrapyramidal reactions/extrapyramidal symptoms, tremor</p>
<p><b>Frequency not reported</b>: Amnesia, autonomic manifestations, balance disorders, convulsions/seizures, extremity numbness/tingling, hyperreflexia, hypersensitivity to light/noise/sound, impaired perception, involuntary movements, prolonged response times, short-term memory loss, vertigo</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Ataxia, coma, dizziness, drowsiness, excessive drowsiness/sleepiness, headache, sedation, somnolence, stupor</p>
<p><b>Uncommon</b> (0.1% to 1%): Brain edema, convulsion, myoclonus, tremor</p>
<p><b>Frequency not reported</b>: Amnesia, balance disorder, central nervous system effects, decreased ability to perform complex mental functions, dysarthria, extrapyramidal symptoms, memory impairment, seizures, slurred speech, transient anterograde amnesia, unsteady gait, vertigo</p>
<p><b>Postmarketing reports</b>: Neuroleptic malignant syndrome, paralysis<sup>[Ref]</sup></p><p>Dose-dependent central nervous system depression, increased sedation, and unsteadiness were associated with increased age.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Oral:</p>
<p><b>Common</b> (1% to 10%): Confusion, depression, unmasking of depression</p>
<p><b>Uncommon</b> (0.1% to 1%): Change in libido, impotence, less intense orgasm/decreased orgasm</p>
<p><b>Rare</b> (0.01% to 0.1%): Change in libido, confusion, decreased orgasm, depression, disinhibition, euphoria, numbed emotions, sleep disturbances, unmasking of depression</p>
<p><b>Frequency not reported</b>: Aggression, aggressive behavior, aggressiveness, agitation/states of agitation, anxiety, behavioral disorder, catatonia, delirium, delusion, dependence, depersonalization, derealization, disorientation, drug withdrawal symptoms, dysphoria, excitement/excitation, hallucinations, hostility, impaired attention/concentration, impotence, inappropriate behavior, increased dreaming, inner restlessness, insomnia, irritability, loss of reality, nightmares, panic attacks, psychoses, rage, restlessness, sexual arousal, sleep disorders, stimulation, suicidal attempt/ideation, tension/states of tension,, withdrawal phenomena</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Confusion, delirium, depression, restlessness, unmasking of depression, visual hallucinations</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal thinking, agitation, ataxia, change in libido, decreased orgasm, hallucinations</p>
<p><b>Frequency not reported</b>: Aggression, agitation, anxiety, disinhibition, excitation, euphoria, hostility, impaired attention/concentration, inappropriate behavior, insomnia, irritability, mania, psychosis, rage, sexual arousal, sleep disturbances, stimulation, suicidal attempt/ideation</p>
<p><b>Postmarketing reports</b>: Acute brain syndrome, nervousness<sup>[Ref]</sup></p><h3>Other</h3><p>Oral:</p>
<p><b>Common</b> (1% to 10%): Asthenia, fatigue, lassitude, weakness</p>
<p><b>Uncommon</b> (0.1% to 1%): Chills</p>
<p><b>Very rare</b> (less than 0.01%): Hypothermia</p>
<p><b>Frequency not reported</b>: Hyperacusis, hyperthermia, paradoxical reactions, rebound phenomena</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Asthenia, crying, fatigue, sobbing</p>
<p><b>Uncommon</b> (0.1% to 1%): Chills</p>
<p><b>Frequency not reported</b>: Depressed hearing, enhanced sensitivity to alcoholic beverages, falls, hypothermia, paradoxical reactions, tinnitus</p>
<p><b>Postmarketing reports</b>: Fatalities<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Oral:</p>
<p><b>Rare</b> (0.01% to 0.1%): Apnea, respiratory depression, worsening of obstructive pulmonary disease, worsening of sleep apnea</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Apnea, hypoventilation, respiratory disorder, respiratory failure</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperventilation</p>
<p><b>Frequency not reported</b>: Airway obstruction, worsening of obstructive pulmonary disease, worsening of sleep apnea</p>
<p><b>Postmarketing reports</b>: Lung edema, lung hemorrhage, pneumothorax, pulmonary hypertension, respiratory arrest<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Oral:</p>
<p><b>Rare</b> (0.01% to 0.1%): Hypotension</p>
<p><b>Frequency not reported</b>: Palpitations, small decreases in blood pressure, tachycardia</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Hypotension</p>
<p><b>Frequency not reported</b>: Decreased blood pressure</p>
<p><b>Postmarketing reports</b>: Arrhythmia, bradycardia, heart arrest/failure, heart block, pericardial effusion, tachycardia, ventricular arrhythmia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Oral:</p>
<p><b>Frequency not reported</b>: Muscle pain, myalgia</p>
<p></p>
<p>Parenteral:</p>
<p><b>Common</b> (1% to 10%): Muscle weakness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Oral:</p>
<p><b>Uncommon</b> (0.1% to 1%): Nausea</p>
<p><b>Rare</b> (0.01% to 0.1%): Constipation, salivation changes</p>
<p><b>Frequency not reported</b>: Abdominal cramps, abdominal spasms, diarrhea, dry mouth, gastrointestinal symptoms, hypersalivation, vomiting</p>
<p></p>
<p>Parenteral:</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased salivation, nausea, vomiting</p>
<p><b>Frequency not reported</b>: Constipation</p>
<p><b>Postmarketing reports</b>: Gastrointestinal hemorrhage<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Oral:</p>
<p><b>Rare</b> (0.01% to 0.1%): Change in appetite, increase in alkaline phosphatase</p>
<p><b>Very rare</b> (less than 0.01%): Hyponatremia</p>
<p><b>Frequency not reported</b>: Loss of appetite</p>
<p></p>
<p>Parenteral:</p>
<p><b>Uncommon</b> (0.1% to 1%): Acidosis, increased alkaline phosphatase</p>
<p><b>Frequency not reported</b>: Hyponatremia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Oral:</p>
<p><b>Rare</b> (0.01% to 0.1%): Allergic dermatitis, rash</p>
<p><b>Frequency not reported</b>: Allergic skin reactions, alopecia, dermatological symptoms, sweating</p>
<p></p>
<p>Parenteral:</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypertension, hypotension</p>
<p><b>Frequency not reported</b>: Allergic skin reactions, alopecia, skin rash<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Oral:</p>
<p><b>Rare</b> (0.01% to 0.1%): Abnormal liver function test values, increase in bilirubin, increase in liver transaminases, jaundice</p>
<p></p>
<p>Parenteral:</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal liver function tests</p>
<p><b>Frequency not reported</b>: Increased bilirubin, increased liver transaminases, jaundice</p>
<p><b>Postmarketing reports</b>: Liver damage<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Oral:</p>
<p><b>Rare</b> (0.01% to 0.1%): Impotence</p>
<p></p>
<p>Parenteral:</p>
<p><b>Uncommon</b> (0.1% to 1%): Impotence</p>
<p><b>Postmarketing reports</b>: Urinary incontinence<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Parenteral:</p>
<p><b>Uncommon</b> (0.1% to 1%): Infection<sup>[Ref]</sup></p><h3>Renal</h3><p>Parenteral:</p>
<p><b>Uncommon</b> (0.1% to 1%): Cystitis<sup>[Ref]</sup></p><h3>Ocular</h3><p>Oral:</p>
<p><b>Rare</b> (0.01% to 0.1%): Blurred vision, diplopia, eye function/visual disturbance</p>
<p></p>
<p>Parenteral:</p>
<p><b>Frequency not reported</b>: Blurred vision, diplopia, visual disturbances<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Oral:</p>
<p><b>Very rare</b> (less than 0.01%): Agranulocytosis, leukopenia, pancytopenia, thrombocytopenia</p>
<p></p>
<p>Parenteral:</p>
<p><b>Frequency not reported</b>: Agranulocytosis, hypochromic anemia, leukocytosis, pancytopenia, thrombocythemia, thrombocytopenia</p>
<p><b>Postmarketing reports</b>: Coagulation disorder<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Oral:</p>
<p><b>Very rare</b> (less than 0.01%): Anaphylactoid reactions, anaphylaxis, hypersensitivity</p>
<p><b>Frequency not reported</b>: Angioedema, hypersensitivity reactions</p>
<p></p>
<p>Parenteral:</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions, anaphylactoid reactions, angioedema, hypersensitivity reactions<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Oral:</p>
<p><b>Very rare</b> (less than 0.01%): Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>
<p></p>
<p>Parenteral:</p>
<p><b>Frequency not reported</b>: SIADH</p>
<p><b>Postmarketing reports</b>: Aggravation of pheochromocytoma<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Ativan (lorazepam)." Wyeth-Ayerst Laboratories, Philadelphia, PA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Lorazepam vs Xanax: What is the difference?</li>
<li>Ativan vs Xanax - What is the difference?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about lorazepam</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>886 Reviews</li>
<li>Drug class: benzodiazepine anticonvulsants</li>
<li>FDA Alerts (5)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lorazepam injection</li>
<li>Lorazepam &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Lorazepam Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Ativan, Lorazepam Intensol</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +5 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Borderline Personality Disorder</li>
<li>Anxiety</li>
<li>Cervical Dystonia</li>
<li>Dysautonomia</li>
<li data-more-config-id="list-data-resources-conditions">... +8 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to lorazepam: compounding powder, injectable solution, intravenous solution, oral concentrate, oral tablet</i></p><h3>General</h3><p>Oral: The most commonly reported side effects included sedation, dizziness, weakness, and unsteadiness.</p><p></p><p>Parenteral: The most commonly reported side effects included somnolence, respiratory failure, hypotension, and injection site reactions (pain and burning).<sup>[Ref]</sup></p><h3>Local</h3><p>Parenteral:</p><p><b>Very common</b> (10% or more): Burning (up to 17%), pain (up to 17%)</p><p><b>Common</b> (1% to 10%): Painful response, redness</p><p><b>Uncommon</b> (0.1% to 1%): Injection site reaction</p><p><b>Frequency not reported</b>: Arteriospasm, gangrene, injection site tolerance<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Oral:</p><p><b>Very common</b> (10% or more): Sedation (up to 15.9%)</p><p><b>Common</b> (1% to 10%): Anterograde amnesia, ataxia, daytime drowsiness, dizziness, drowsiness, unsteadiness</p><p><b>Rare</b> (0.01% to 0.1%): Dysarthria, headache, memory impairment, reduced alertness, slurred speech, transient anterograde amnesia</p><p><b>Very rare</b> (less than 0.01%): Coma, extrapyramidal reactions/extrapyramidal symptoms, tremor</p><p><b>Frequency not reported</b>: Amnesia, autonomic manifestations, balance disorders, convulsions/seizures, extremity numbness/tingling, hyperreflexia, hypersensitivity to light/noise/sound, impaired perception, involuntary movements, prolonged response times, short-term memory loss, vertigo</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Ataxia, coma, dizziness, drowsiness, excessive drowsiness/sleepiness, headache, sedation, somnolence, stupor</p><p><b>Uncommon</b> (0.1% to 1%): Brain edema, convulsion, myoclonus, tremor</p><p><b>Frequency not reported</b>: Amnesia, balance disorder, central nervous system effects, decreased ability to perform complex mental functions, dysarthria, extrapyramidal symptoms, memory impairment, seizures, slurred speech, transient anterograde amnesia, unsteady gait, vertigo</p><p><b>Postmarketing reports</b>: Neuroleptic malignant syndrome, paralysis<sup>[Ref]</sup></p><p>Dose-dependent central nervous system depression, increased sedation, and unsteadiness were associated with increased age.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Confusion, depression, unmasking of depression</p><p><b>Uncommon</b> (0.1% to 1%): Change in libido, impotence, less intense orgasm/decreased orgasm</p><p><b>Rare</b> (0.01% to 0.1%): Change in libido, confusion, decreased orgasm, depression, disinhibition, euphoria, numbed emotions, sleep disturbances, unmasking of depression</p><p><b>Frequency not reported</b>: Aggression, aggressive behavior, aggressiveness, agitation/states of agitation, anxiety, behavioral disorder, catatonia, delirium, delusion, dependence, depersonalization, derealization, disorientation, drug withdrawal symptoms, dysphoria, excitement/excitation, hallucinations, hostility, impaired attention/concentration, impotence, inappropriate behavior, increased dreaming, inner restlessness, insomnia, irritability, loss of reality, nightmares, panic attacks, psychoses, rage, restlessness, sexual arousal, sleep disorders, stimulation, suicidal attempt/ideation, tension/states of tension,, withdrawal phenomena</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Confusion, delirium, depression, restlessness, unmasking of depression, visual hallucinations</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal thinking, agitation, ataxia, change in libido, decreased orgasm, hallucinations</p><p><b>Frequency not reported</b>: Aggression, agitation, anxiety, disinhibition, excitation, euphoria, hostility, impaired attention/concentration, inappropriate behavior, insomnia, irritability, mania, psychosis, rage, sexual arousal, sleep disturbances, stimulation, suicidal attempt/ideation</p><p><b>Postmarketing reports</b>: Acute brain syndrome, nervousness<sup>[Ref]</sup></p><h3>Other</h3><p>Oral:</p><p><b>Common</b> (1% to 10%): Asthenia, fatigue, lassitude, weakness</p><p><b>Uncommon</b> (0.1% to 1%): Chills</p><p><b>Very rare</b> (less than 0.01%): Hypothermia</p><p><b>Frequency not reported</b>: Hyperacusis, hyperthermia, paradoxical reactions, rebound phenomena</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Asthenia, crying, fatigue, sobbing</p><p><b>Uncommon</b> (0.1% to 1%): Chills</p><p><b>Frequency not reported</b>: Depressed hearing, enhanced sensitivity to alcoholic beverages, falls, hypothermia, paradoxical reactions, tinnitus</p><p><b>Postmarketing reports</b>: Fatalities<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Oral:</p><p><b>Rare</b> (0.01% to 0.1%): Apnea, respiratory depression, worsening of obstructive pulmonary disease, worsening of sleep apnea</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Apnea, hypoventilation, respiratory disorder, respiratory failure</p><p><b>Uncommon</b> (0.1% to 1%): Hyperventilation</p><p><b>Frequency not reported</b>: Airway obstruction, worsening of obstructive pulmonary disease, worsening of sleep apnea</p><p><b>Postmarketing reports</b>: Lung edema, lung hemorrhage, pneumothorax, pulmonary hypertension, respiratory arrest<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Oral:</p><p><b>Rare</b> (0.01% to 0.1%): Hypotension</p><p><b>Frequency not reported</b>: Palpitations, small decreases in blood pressure, tachycardia</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Hypotension</p><p><b>Frequency not reported</b>: Decreased blood pressure</p><p><b>Postmarketing reports</b>: Arrhythmia, bradycardia, heart arrest/failure, heart block, pericardial effusion, tachycardia, ventricular arrhythmia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>Oral:</p><p><b>Frequency not reported</b>: Muscle pain, myalgia</p><p></p><p>Parenteral:</p><p><b>Common</b> (1% to 10%): Muscle weakness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Oral:</p><p><b>Uncommon</b> (0.1% to 1%): Nausea</p><p><b>Rare</b> (0.01% to 0.1%): Constipation, salivation changes</p><p><b>Frequency not reported</b>: Abdominal cramps, abdominal spasms, diarrhea, dry mouth, gastrointestinal symptoms, hypersalivation, vomiting</p><p></p><p>Parenteral:</p><p><b>Uncommon</b> (0.1% to 1%): Increased salivation, nausea, vomiting</p><p><b>Frequency not reported</b>: Constipation</p><p><b>Postmarketing reports</b>: Gastrointestinal hemorrhage<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Oral:</p><p><b>Rare</b> (0.01% to 0.1%): Change in appetite, increase in alkaline phosphatase</p><p><b>Very rare</b> (less than 0.01%): Hyponatremia</p><p><b>Frequency not reported</b>: Loss of appetite</p><p></p><p>Parenteral:</p><p><b>Uncommon</b> (0.1% to 1%): Acidosis, increased alkaline phosphatase</p><p><b>Frequency not reported</b>: Hyponatremia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Oral:</p><p><b>Rare</b> (0.01% to 0.1%): Allergic dermatitis, rash</p><p><b>Frequency not reported</b>: Allergic skin reactions, alopecia, dermatological symptoms, sweating</p><p></p><p>Parenteral:</p><p><b>Uncommon</b> (0.1% to 1%): Hypertension, hypotension</p><p><b>Frequency not reported</b>: Allergic skin reactions, alopecia, skin rash<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Oral:</p><p><b>Rare</b> (0.01% to 0.1%): Abnormal liver function test values, increase in bilirubin, increase in liver transaminases, jaundice</p><p></p><p>Parenteral:</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal liver function tests</p><p><b>Frequency not reported</b>: Increased bilirubin, increased liver transaminases, jaundice</p><p><b>Postmarketing reports</b>: Liver damage<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Oral:</p><p><b>Rare</b> (0.01% to 0.1%): Impotence</p><p></p><p>Parenteral:</p><p><b>Uncommon</b> (0.1% to 1%): Impotence</p><p><b>Postmarketing reports</b>: Urinary incontinence<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Parenteral:</p><p><b>Uncommon</b> (0.1% to 1%): Infection<sup>[Ref]</sup></p><h3>Renal</h3><p>Parenteral:</p><p><b>Uncommon</b> (0.1% to 1%): Cystitis<sup>[Ref]</sup></p><h3>Ocular</h3><p>Oral:</p><p><b>Rare</b> (0.01% to 0.1%): Blurred vision, diplopia, eye function/visual disturbance</p><p></p><p>Parenteral:</p><p><b>Frequency not reported</b>: Blurred vision, diplopia, visual disturbances<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Oral:</p><p><b>Very rare</b> (less than 0.01%): Agranulocytosis, leukopenia, pancytopenia, thrombocytopenia</p><p></p><p>Parenteral:</p><p><b>Frequency not reported</b>: Agranulocytosis, hypochromic anemia, leukocytosis, pancytopenia, thrombocythemia, thrombocytopenia</p><p><b>Postmarketing reports</b>: Coagulation disorder<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Oral:</p><p><b>Very rare</b> (less than 0.01%): Anaphylactoid reactions, anaphylaxis, hypersensitivity</p><p><b>Frequency not reported</b>: Angioedema, hypersensitivity reactions</p><p></p><p>Parenteral:</p><p><b>Frequency not reported</b>: Anaphylactic reactions, anaphylactoid reactions, angioedema, hypersensitivity reactions<sup>[Ref]</sup></p><h3>Endocrine</h3><p>Oral:</p><p><b>Very rare</b> (less than 0.01%): Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p><p></p><p>Parenteral:</p><p><b>Frequency not reported</b>: SIADH</p><p><b>Postmarketing reports</b>: Aggravation of pheochromocytoma<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Ativan (lorazepam)." Wyeth-Ayerst Laboratories, Philadelphia, PA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Lorazepam vs Xanax: What is the difference?</li>
<li>Ativan vs Xanax - What is the difference?</li>
</ul><h2>More about lorazepam</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>886 Reviews</li>
<li>Drug class: benzodiazepine anticonvulsants</li>
<li>FDA Alerts (5)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lorazepam injection</li>
<li>Lorazepam &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Lorazepam Injection &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +5 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Borderline Personality Disorder</li>
<li>Anxiety</li>
<li>Cervical Dystonia</li>
<li>Dysautonomia</li>
<li data-more-config-id="list-data-resources-conditions">... +8 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>